{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:47:15Z","timestamp":1790318835507,"version":"4.1.0"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000651","name":"Leukaemia Lymphoma Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000651","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001273","name":"Children with Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001273","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2015,1,1]]},"DOI":"10.15252\/embr.201439583","type":"journal-article","created":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T10:40:50Z","timestamp":1418899250000},"page":"44-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Stem and progenitor cell dysfunction in human trisomies"],"prefix":"10.1038","volume":"16","author":[{"given":"Binbin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"BFEMBR201439583_CR1","volume-title":"The National Down Syndrome Cytogenetic Register for England and Wales: 2012 Annual Report","author":"JK Morris","year":"2014","unstructured":"Morris JK, Springett A (2014) The National Down Syndrome Cytogenetic Register for England and Wales: 2012 Annual Report. London: Public Health England"},{"key":"BFEMBR201439583_CR2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.111.4.777","volume":"111","author":"SA Rasmussen","year":"2003","unstructured":"Rasmussen SA, Wong LC, May KM, Friedman JM (2003) Population\u2010based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111: 777\u2013784","journal-title":"Pediatrics"},{"key":"BFEMBR201439583_CR3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1542\/peds.2011-2139","volume":"129","author":"KE Nelson","year":"2012","unstructured":"Nelson KE, Hexem KR, Feudtner C (2012) Inpatient hospital care of children with trisomy 13 and trisomy 18 in the United States. Pediatrics 129: 869\u2013876","journal-title":"Pediatrics"},{"key":"BFEMBR201439583_CR4","doi-asserted-by":"publisher","unstructured":"Liang CA, Braddock BA, Heithaus JL, Christensen KM, Braddock SR, Carey JC (2013) Reported communication ability of persons with trisomy 18 and trisomy 13. Dev Neurorehabil doi: https:\/\/doi.org\/10.3109\/17518423.2013.847980","DOI":"10.3109\/17518423.2013.847980"},{"key":"BFEMBR201439583_CR5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ejhg.2012.294","volume":"21","author":"J Wu","year":"2013","unstructured":"Wu J, Morris JK (2013) The population prevalence of Down's syndrome in England and Wales in 2011. Eur J Hum Genet 21: 1016\u20131019","journal-title":"Eur J Hum Genet"},{"key":"BFEMBR201439583_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1998.5335","volume":"51","author":"SE Antonarakis","year":"1998","unstructured":"Antonarakis SE (1998) 10 years of Genomics, chromosome 21, and Down syndrome. Genomics 51: 1\u201316","journal-title":"Genomics"},{"key":"BFEMBR201439583_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pbc.20165","volume":"44","author":"JA Ross","year":"2005","unstructured":"Ross JA, Spector LG, Robison LL, Olshan AF (2005) Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer 44: 8\u201312","journal-title":"Pediatr Blood Cancer"},{"key":"BFEMBR201439583_CR8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrg1448","volume":"5","author":"SE Antonarakis","year":"2004","unstructured":"Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet 5: 725\u2013738","journal-title":"Nat Rev Genet"},{"key":"BFEMBR201439583_CR9","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pgen.0020050","volume":"2","author":"RJ Roper","year":"2006","unstructured":"Roper RJ, Reeves RH (2006) Understanding the basis for Down syndrome phenotypes. PLoS Genet 2: e50","journal-title":"PLoS Genet"},{"key":"BFEMBR201439583_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1542\/peds.2011-1605","volume":"128","author":"MJ Bull","year":"2011","unstructured":"Bull MJ, the Committee on Genetics (2011) Health supervision for children with Down syndrome. Pediatrics 128: 393\u2013406","journal-title":"Pediatrics"},{"key":"BFEMBR201439583_CR11","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","volume":"122","author":"I Roberts","year":"2013","unstructured":"Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, Vallance G, Perkins K, Marchi E, McGowan S et\u00a0al (2013) GATA1\u2010mutant clones are\u00a0frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood 122: 3908\u20133917","journal-title":"Blood"},{"key":"BFEMBR201439583_CR12","first-page":"403","volume":"100","author":"WB Zigman","year":"1996","unstructured":"Zigman WB, Schupf N, Sersen E, Silverman W (1996) Prevalence of dementia in adults with and without Down syndrome. Am J Ment Retard 100: 403\u2013412","journal-title":"Am J Ment Retard"},{"key":"BFEMBR201439583_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000007940","volume":"39","author":"Y Sekijima","year":"1998","unstructured":"Sekijima Y, Ikeda S, Tokuda T, Satoh S, Hidaka H, Hidaka E, Ishikawa M, Yanagisawa N (1998) Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. Eur Neurol 39: 234\u2013237","journal-title":"Eur Neurol"},{"key":"BFEMBR201439583_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2788.2000.00263.x","volume":"44","author":"AJ Holland","year":"2000","unstructured":"Holland AJ, Hon J, Huppert FA, Stevens F (2000) Incidence and course of dementia in people with Down's syndrome: findings from a population\u2010based study. J Intellect Disabil Res 44: 138\u2013146","journal-title":"J Intellect Disabil Res"},{"key":"BFEMBR201439583_CR15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/gps.502","volume":"16","author":"J Tyrrell","year":"2001","unstructured":"Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A, McLaughlin M, Gill M, Lawlor BA (2001) Dementia in people with Down's syndrome. Int J Geriatr Psychiatry 16: 1168\u20131174","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFEMBR201439583_CR16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2788.2006.00842.x","volume":"50","author":"A Coppus","year":"2006","unstructured":"Coppus A, Evenhuis H, Verberne GJ, Visser F, van Gool P, Eikelenboom P, van Duijn C (2006) Dementia and mortality in persons with Down's syndrome. J Intellect Disabil Res 50: 768\u2013777","journal-title":"J Intellect Disabil Res"},{"key":"BFEMBR201439583_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-54299-1.00006-6","volume":"197","author":"IT Lott","year":"2012","unstructured":"Lott IT (2012) Neurological phenotypes for Down syndrome across the life span. Prog Brain Res 197: 101\u2013121","journal-title":"Prog Brain Res"},{"key":"BFEMBR201439583_CR18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/jir.12026","volume":"58","author":"EJ Glasson","year":"2014","unstructured":"Glasson EJ, Dye DE, Bittles AH (2014) The triple challenges associated with age\u2010related comorbidities in Down syndrome. J Intellect Disabil Res 58: 393\u2013398","journal-title":"J Intellect Disabil Res"},{"key":"BFEMBR201439583_CR19","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awu173","volume":"137","author":"SL Hartley","year":"2014","unstructured":"Hartley SL, Handen BL, Devenney DA, Hardison R, Mihaila I, Proce JC, Cohen AD, Klunk WE, Mailick MR, Johnson SC et\u00a0al (2014) Cognitive functioning in relation to brain amyloid\u2010\u03b2 in healthy adults with Down syndrome. Brain 137: 2556\u20132563","journal-title":"Brain"},{"key":"BFEMBR201439583_CR20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12530","volume":"501","author":"M Adorno","year":"2013","unstructured":"Adorno M, Sikandar S, Mitra SS, Kuo A, Nicolis Di Robilant B, Haro\u2010Acosta V, Ouadah Y, Quarta M, Rodriguez J, Qian D et\u00a0al (2013) Usp16 contributes to somatic stem\u2010cell defects in Down's syndrome. Nature 501: 380\u2013384","journal-title":"Nature"},{"key":"BFEMBR201439583_CR21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.13096","volume":"167","author":"I Roberts","year":"2014","unstructured":"Roberts I, Izraeli S (2014) Haematopoietic development and leukaemia in Down syndrome. Br J Haematol 167: 587\u2013599","journal-title":"Br J Haematol"},{"key":"BFEMBR201439583_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc3355","volume":"12","author":"D Nizetic","year":"2012","unstructured":"Nizetic D, Groet J (2012) Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nat Rev Cancer 12: 721\u2013732","journal-title":"Nat Rev Cancer"},{"key":"BFEMBR201439583_CR23","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1534\/genetics.111.131391","volume":"189","author":"SL Deitz","year":"2011","unstructured":"Deitz SL, Roper RJ (2011) Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice. Genetics 189: 1487\u20131495","journal-title":"Genetics"},{"key":"BFEMBR201439583_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ddrr.1127","volume":"18","author":"A Ruparelia","year":"2013","unstructured":"Ruparelia A, Pearn ML, Mobley WC (2013) Aging and intellectual disability: insights from mouse models of Down syndrome. Dev Disabil Res Rev 18: 43\u201350","journal-title":"Dev Disabil Res Rev"},{"key":"BFEMBR201439583_CR25","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1126\/science.1114535","volume":"309","author":"A O'Doherty","year":"2005","unstructured":"O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D et\u00a0al (2005) An aneuploid mouse strain carrying human chromosome 21 with down syndrome phenotypes. Science 309: 2033\u20132037","journal-title":"Science"},{"key":"BFEMBR201439583_CR26","doi-asserted-by":"crossref","first-page":"e60482","DOI":"10.1371\/journal.pone.0060482","volume":"8","author":"SM Gribble","year":"2013","unstructured":"Gribble SM, Wiseman FK, Clayton S, Prigmore E, Langley E, Yang F, Maguire S, Fu B, Rajan D, Sheppard O et\u00a0al (2013) Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome. PLoS ONE 8: e60482","journal-title":"PLoS ONE"},{"key":"BFEMBR201439583_CR27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/hmg\/ddm086","volume":"16","author":"Z Li","year":"2007","unstructured":"Li Z, Yu T, Morishima M, Pao A, LaDuca J, Conroy J, Nowak N, Matsui S, Shiraishi I, Yu YE (2007) Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16: 1359\u20131366","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR28","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","volume":"19","author":"T Yu","year":"2010","unstructured":"Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, Asrar S, Pao A, Chen R, Fan N et\u00a0al (2010) A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet 19: 2780\u20132791","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","volume":"1366","author":"T Yu","year":"2012","unstructured":"Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, Kleschevnikov A, Bechard AR, Asrar S, Chen R et\u00a0al (2012) Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long\u2010term potentiation and cognitive behaviors in mice. Brain Res 1366: 162\u2013171","journal-title":"Brain Res"},{"key":"BFEMBR201439583_CR30","doi-asserted-by":"crossref","first-page":"e1002724","DOI":"10.1371\/journal.pgen.1002724","volume":"8","author":"M Raveau","year":"2012","unstructured":"Raveau M, Lignon JM, Naleso V, Duchon A, Groner Y, Sharp AJ, Dembele D, Brault V, Herault Y (2012) The App\u2010Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model. PLoS Genet 8: e1002724","journal-title":"PLoS Genet"},{"key":"BFEMBR201439583_CR31","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1093\/hmg\/ddp438","volume":"18","author":"P Lopes Pereira","year":"2009","unstructured":"Lopes Pereira P, Magnol L, Sahun I, Brault V, Duchon A, Prandini P, Gruart A, Bizot J\u2010C, Chadefaux\u2010Vekemans B, Deutsch S et\u00a0al (2009) A new mouse model for the trisomy of the Abcg1\u2010U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet 18: 4756\u20134769","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1534\/genetics.114.165241","volume":"197","author":"I Sahun","year":"2014","unstructured":"Sahun I, Marechal D, Pereira PL, Nalesso V, Gruart A, Garcia JMD, Antonarakis SE, Dierssen M, Herault Y (2014) Cognition and hippocampal plasticity in the mouse is altered by monosomy of a genomic region implicated in Down syndrome. Genetics 197: 899\u2013912","journal-title":"Genetics"},{"key":"BFEMBR201439583_CR33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00335-007-9030-8","volume":"18","author":"CS Moore","year":"2007","unstructured":"Moore CS, Roper RJ (2007) The power of comparative and developmental studies for mouse models of Down syndrome. Mamm Genome 18: 431\u2013443","journal-title":"Mamm Genome"},{"key":"BFEMBR201439583_CR34","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1093\/hmg\/ddp010","volume":"18","author":"FK Wiseman","year":"2009","unstructured":"Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM (2009) Down syndrome\u2010 recent progress and future prospects. Hum Mol Genet 18: R75\u2013R83","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR35","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1242\/dmm.008078","volume":"4","author":"E Lana\u2010Elola","year":"2011","unstructured":"Lana\u2010Elola E, Watson\u2010Scales SD, Fisher EM, Tybulewicz VL (2011) Down syndrome: searching for the genetic culprits. Dis Model Mech 4: 586\u2013595","journal-title":"Dis Model Mech"},{"key":"BFEMBR201439583_CR36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1242\/dmm.007716","volume":"4","author":"I Das","year":"2011","unstructured":"Das I, Reeves RH (2011) The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech 4: 596\u2013606","journal-title":"Dis Model Mech"},{"key":"BFEMBR201439583_CR37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","volume":"22","author":"A Duchon","year":"2011","unstructured":"Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y (2011) Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome 22: 674\u2013684","journal-title":"Mamm Genome"},{"key":"BFEMBR201439583_CR38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","volume":"22","author":"LG Reinholdt","year":"2011","unstructured":"Reinholdt LG, Ding Y, Gilbert GJ, Czechanski A, Solzak JP, Roper RJ, Johnson MT, Donahue LR, Lutz C, Davisson MT (2011) Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn. Mamm Genome 22: 685\u2013691","journal-title":"Mamm Genome"},{"key":"BFEMBR201439583_CR39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-444-54299-1.00007-8","volume":"197","author":"JO Edgin","year":"2012","unstructured":"Edgin JO, Mason GM, Span\u00f2 G, Fern\u00e1ndez A, Nadel L (2012) Human and mouse cognitive phenotypes in Down syndrome: implications for assessment. Prog Brain Res 197: 123\u2013151","journal-title":"Prog Brain Res"},{"key":"BFEMBR201439583_CR40","first-page":"8","volume":"3","author":"L Zhang","year":"2012","unstructured":"Zhang L, Fu D, Belichenko PV, Liu C, Kleschevnikov AM, Pao A, Liang P, Clapcote SJ, Mobley WC, Yu YE (2012) Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. Bioeng Bugs 3: 8\u201312","journal-title":"Bioeng Bugs"},{"key":"BFEMBR201439583_CR41","doi-asserted-by":"crossref","first-page":"584071","DOI":"10.1155\/2012\/584071","volume":"2012","author":"N Rueda","year":"2012","unstructured":"Rueda N, Florez J, Martinez\u2010Cue C (2012) Mouse models of Down syndrome to unravel causes of mental disabilities. Neural Plast 2012: 584071","journal-title":"Neural Plast"},{"key":"BFEMBR201439583_CR42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00439-013-1407-z","volume":"133","author":"C Liu","year":"2014","unstructured":"Liu C, Morishima M, Jiang X, Yu T, Meng K, Kay D, Pao A, Ye P, Parmacek MS, Yu YE (2014) Engineered chromosome\u2010based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome\u2010associated heart defects in mice. Hum Genet 133: 743\u2013753","journal-title":"Hum Genet"},{"key":"BFEMBR201439583_CR43","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","volume":"112","author":"O Tunstall\u2010Pedoe","year":"2008","unstructured":"Tunstall\u2010Pedoe O, Roy A, Karadimitris A, de la Fuente J, Fisk NM, Bennett P, Norton A, Vyas P, Roberts I (2008) Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood 112: 4507\u20134511","journal-title":"Blood"},{"key":"BFEMBR201439583_CR44","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2008-05-157859","volume":"112","author":"ST Chou","year":"2008","unstructured":"Chou ST, Opalinska JB, Yao Y, Fernandes MA, Kalota A, Brooks JSJ, Choi JK, Gewirtz AM, Danet\u2010Desnoyers G\u2010A, Nemiroff RL et\u00a0al (2008) Trisomy 21 enhances human fetal erythro\u2010megakaryocytic development. Blood 112: 4503\u20134506","journal-title":"Blood"},{"key":"BFEMBR201439583_CR45","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1073\/pnas.1211405109","volume":"109","author":"A Roy","year":"2012","unstructured":"Roy A, Cowan G, Mead AJ, Filippi S, Bohn G, Chaidos A, Tunstall O, Chan JKY, Choolani M, Bennett P et\u00a0al (2012) Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci USA 109: 17579\u201317584","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR46","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.1215468109","volume":"109","author":"GA MacLean","year":"2012","unstructured":"MacLean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH (2012) Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic induced pluripotent cells. Proc Natl Acad Sci USA 109: 17567\u201317572","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR47","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1073\/pnas.1211175109","volume":"109","author":"ST Chou","year":"2012","unstructured":"Chou ST, Byrska\u2010Bishop M, Tober JM, Yao Y, Vandorn D, Opalinska JB, Mills JA, Choi JK, Speck NA, Gadue P et\u00a0al (2012) Trisomy 21\u2010associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci USA 109: 17573\u201317578","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2007-04-085670","volume":"111","author":"G Kirsammer","year":"2008","unstructured":"Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, Crispino JD (2008) Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 111: 767\u2013775","journal-title":"Blood"},{"key":"BFEMBR201439583_CR49","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2008-06-161422","volume":"113","author":"CL Carmichael","year":"2009","unstructured":"Carmichael CL, Majewski IJ, Alexander WS, Metcalf D, Hilton DJ, Hewitt CA, Scott HS (2009) Hematopoietic defects in the Ts1Cje mouse model of Down syndrome. Blood 113: 1929\u20131937","journal-title":"Blood"},{"key":"BFEMBR201439583_CR50","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2009-06-227629","volume":"115","author":"KA Alford","year":"2010","unstructured":"Alford KA, Slender A, Vanes L, Li Z, Fisher EM, Nizetic D, Orkin SH, Roberts I, Tybulewicz VL (2010) Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood 115: 2928\u20132937","journal-title":"Blood"},{"key":"BFEMBR201439583_CR51","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1172\/JCI60455","volume":"122","author":"S Malinge","year":"2012","unstructured":"Malinge S, Bliss\u2010Moreau M, Kirsammer G, Diebold L, Chlon T, Gurbuxani S, Crispino JD (2012) Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. J Clin Invest 122: 948\u2013962","journal-title":"J Clin Invest"},{"key":"BFEMBR201439583_CR52","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/onc.2010.351","volume":"29","author":"S De Vita","year":"2010","unstructured":"De Vita S, Canzonetta C, Mullighan C, Delom F, Groet J, Baldo C, Vanes L, Dagna\u2010Bricarelli F, Hoischen A, Veltman J et\u00a0al (2010) Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome. Oncogene 29: 6102\u20136114","journal-title":"Oncogene"},{"key":"BFEMBR201439583_CR53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M (2000) Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355: 165\u2013169","journal-title":"Lancet"},{"key":"BFEMBR201439583_CR54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(00)00435-6","volume":"2","author":"H Hasle","year":"2001","unstructured":"Hasle H (2001) Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2: 429\u2013436","journal-title":"Lancet Oncol"},{"key":"BFEMBR201439583_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1469-1809.2001.6520167.x","volume":"65","author":"C Hermon","year":"2001","unstructured":"Hermon C, Alberman E, Beral V, Swerdlow AJ (2001) Mortality and cancer in persons with Down's syndrome, their parents and siblings. Ann Hum Genet 65: 167\u2013176","journal-title":"Ann Hum Genet"},{"key":"BFEMBR201439583_CR56","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","volume":"359","author":"Q Yang","year":"2002","unstructured":"Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population\u2010based study. Lancet 359: 1019\u20131025","journal-title":"Lancet"},{"key":"BFEMBR201439583_CR57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archinte.163.6.705","volume":"163","author":"DA Hill","year":"2003","unstructured":"Hill DA, Gridely G, Cnattingius S, Mellemkjaer L, Linet M, Adami HQ, Olsen JH, Nyren O, Fraumeni JF Jr (2003) Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163: 705\u2013711","journal-title":"Arch Intern Med"},{"key":"BFEMBR201439583_CR58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/adc.2003.046219","volume":"89","author":"M Goldacre","year":"2004","unstructured":"Goldacre M, Wotton CJ, Seagroate V, Yeates D (2004) Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 89: 1014\u20131017","journal-title":"Arch Dis Child"},{"key":"BFEMBR201439583_CR59","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.21518","volume":"118","author":"K Patja","year":"2006","unstructured":"Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M (2006) Cancer incidence of persons with down syndrome in Finland: a population\u2010based study. Int J Cancer 118: 1769\u20131772","journal-title":"Int J Cancer"},{"key":"BFEMBR201439583_CR60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3021","volume":"11","author":"D Gilbert","year":"2011","unstructured":"Gilbert D, Rapley E, Shipley J (2011) Testicular germ cell tumours: predisposition genes and the male germ cell nice. Nat Rev Cancer 11: 278\u2013288","journal-title":"Nat Rev Cancer"},{"key":"BFEMBR201439583_CR61","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","volume":"113","author":"S Malinge","year":"2009","unstructured":"Malinge S, Izraeli S, Crispino JD (2009) Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 113: 2619\u20132628","journal-title":"Blood"},{"key":"BFEMBR201439583_CR62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.siny.2012.02.010","volume":"17","author":"A Roy","year":"2012","unstructured":"Roy A, Roberts I, Vyas P (2012b) Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome. Semin Fetal Neonatal Med 17: 196\u2013201","journal-title":"Semin Fetal Neonatal Med"},{"key":"BFEMBR201439583_CR63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 32: 148\u2013152","journal-title":"Nat Genet"},{"key":"BFEMBR201439583_CR64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2002-11-3599","volume":"102","author":"L Rainis","year":"2003","unstructured":"Rainis L, Bercovich D, Strehl S, Teigler\u2010Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G et\u00a0al (2003) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102: 981\u2013986","journal-title":"Blood"},{"key":"BFEMBR201439583_CR65","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","volume":"101","author":"JK Hitzler","year":"2003","unstructured":"Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101: 4301\u20134304","journal-title":"Blood"},{"key":"BFEMBR201439583_CR66","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(03)13266-7","volume":"361","author":"J Groet","year":"2003","unstructured":"Groet J, McElwaine S, Spinelli M, Rinaldi A, Burtscher I, Mulligan C, Mensah A, Cavani S, Dagna\u2010Bricarelli F, Basso G et\u00a0al (2003) Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet 361: 1617\u20131620","journal-title":"Lancet"},{"key":"BFEMBR201439583_CR67","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","volume":"103","author":"M Ahmed","year":"2004","unstructured":"Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D et\u00a0al (2004) Natural history of GATA1 mutations in Down syndrome. Blood 103: 2480\u20132489","journal-title":"Blood"},{"key":"BFEMBR201439583_CR68","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ng1825","volume":"38","author":"LM Hollanda","year":"2006","unstructured":"Hollanda LM, Lima CSP, Cunha AF, Albuquerque DM, Vassallo J, Ozelo MC, Joazeiro PP, Saad STO, Costa FF (2006) An inherited mutation leading to production of only the short isoform of GATA\u20101 is associated with impaired erythropoiesis. Nat Genet 38: 807\u2013812","journal-title":"Nat Genet"},{"key":"BFEMBR201439583_CR69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood-2013-06-509463","volume":"123","author":"TD Buitenkamp","year":"2014","unstructured":"Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, van den Heuvel\u2010Eibrink MM, Pieters R, Korbijn CM, Silverman LB, Schmiegelow K et\u00a0al (2014) Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood 123: 70\u201377","journal-title":"Blood"},{"key":"BFEMBR201439583_CR70","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","volume":"372","author":"D Bercovich","year":"2008","unstructured":"Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, Shochat C, Cazzaniga G, Biondi A, Basso G et\u00a0al (2008) Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 372: 1484\u20131492","journal-title":"Lancet"},{"key":"BFEMBR201439583_CR71","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","volume":"115","author":"L Hertzberg","year":"2010","unstructured":"Hertzberg L, Vendramini E, Ganmore I, Cazzaniga G, Schmitz M, Chalker J, Shiloh R, Iacobucci I, Shochat C, Zeligson S et\u00a0al (2010) Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood 115: 1006\u20131017","journal-title":"Blood"},{"key":"BFEMBR201439583_CR72","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","volume":"41","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Collins\u2010Underwood JR, Phillips LA, Loudin MG, Liu W, Zhang J, Ma J, Coustan\u2010Smith E, Harvey RC, Willman CL et\u00a0al (2009) Rearrangement of CRLF2 in B\u2010progenitor\u2010 and Down syndrome\u2010associated acute lymphoblastic leukemia. Nat Genet 41: 1243\u20131246","journal-title":"Nat Genet"},{"key":"BFEMBR201439583_CR73","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","volume":"114","author":"LJ Russell","year":"2009","unstructured":"Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, Chapiro E, Gesk S, Griffiths M et\u00a0al (2009) Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B\u2010cell precursor acute lymphoblastic leukemia. Blood 114: 2688\u20132698","journal-title":"Blood"},{"key":"BFEMBR201439583_CR74","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","volume":"208","author":"C Shochat","year":"2011","unstructured":"Shochat C, Tal N, Bandapalli OR, Palmi C, Ganmore I, te Kronnie G, Cario G, Cazzaniga G, Kulozik AE, Stanulla M et\u00a0al (2011) Gain\u2010of\u2010function mutations in interleukin\u20107 receptor\u2010{alpha} (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 208: 901\u2013908","journal-title":"J Exp Med"},{"key":"BFEMBR201439583_CR75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-013-1337-x","volume":"71","author":"N Tal","year":"2014","unstructured":"Tal N, Shochat C, Geron I, Bercovich D, Izraeli S (2014) Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia. Cell Mol Life Sci 71: 365\u2013378","journal-title":"Cell Mol Life Sci"},{"key":"BFEMBR201439583_CR76","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1038\/ncomms5654","volume":"5","author":"SI Nikolaev","year":"2014","unstructured":"Nikolaev SI, Garieri M, Santoni F, Falconnet E, Ribaux P, Guipponi M, Murray A, Groet J, Giarin E, Basso G et\u00a0al (2014) Frequent cases of Ras\u2010mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nat Commun 5: 4654\u20134659","journal-title":"Nat Commun"},{"key":"BFEMBR201439583_CR77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3104\/reports.31","volume":"2","author":"VP Prasher","year":"1994","unstructured":"Prasher VP (1994) Screening of medical problems in adults with Down syndrome. Downs Syndr Res Pract 2: 59\u201366","journal-title":"Downs Syndr Res Pract"},{"key":"BFEMBR201439583_CR78","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2006.04.167","volume":"345","author":"M Zana","year":"2006","unstructured":"Zana M, Szecsenyi A, Czibula A, Bjelik A, Juhasz A, Rimanoczy A, Szabo K, Vetro A, Szucs P, Varkonyi A et\u00a0al (2006) Age\u2010dependent oxidative stress\u2010induced DNA damage in Down's lymphocytes. Biochem Biophys Res Commun 345: 726\u2013733","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMBR201439583_CR79","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2249.2012.04610.x","volume":"169","author":"FP Pellegrini","year":"2012","unstructured":"Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, Mortara L, Accolla RS, Nespoli L (2012) Down syndrome, auto\u2010immunity and T regulatory cells. Clin Exp Immunol 169: 238\u2013243","journal-title":"Clin Exp Immunol"},{"key":"BFEMBR201439583_CR80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11845-008-0223-2","volume":"178","author":"S McLean","year":"2009","unstructured":"McLean S, McHale C, Enright H (2009) Hematological abnormalities in adult patients with Down's syndrome. Ir J Med Sci 178: 35\u201338","journal-title":"Ir J Med Sci"},{"key":"BFEMBR201439583_CR81","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/00006450-200006000-00002","volume":"47","author":"A Zipursky","year":"2000","unstructured":"Zipursky A (2000) Susceptibility to leukemia and resistance to solid tumors in Down syndrome. Pediatr Res 47: 704","journal-title":"Pediatr Res"},{"key":"BFEMBR201439583_CR82","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-10-3446","volume":"106","author":"JA Whitlock","year":"2005","unstructured":"Whitlock JA, Sather HN, Gaynon P, Robison LL, Wells RJ, Trigg M, Heerema NA, Bhatia S (2005) Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 106: 4043\u20134049","journal-title":"Blood"},{"key":"BFEMBR201439583_CR83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","volume":"156","author":"MA Kusters","year":"2009","unstructured":"Kusters MA, Verstegen RH, Gemen EF, de Vries E (2009) Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 156: 189\u2013193","journal-title":"Clin Exp Immunol"},{"key":"BFEMBR201439583_CR84","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.cell.2007.05.014","volume":"129","author":"CR Walkley","year":"2007","unstructured":"Walkley CR, Olsen GH, Dworkin S, Fabb SA, Swann J, McArthur GA, Westmoreland SV, Chambon P, Scadden DT, Purton LE (2007a) A Microenvironment\u2010induced myeloproliferative syndrome caused by retinoic acid receptor \u03b3 deficiency. Cell 129: 1097\u20131110","journal-title":"Cell"},{"key":"BFEMBR201439583_CR85","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2007.03.055","volume":"129","author":"CR Walkley","year":"2007","unstructured":"Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH (2007b) Rb regulates interactions between hematopoietic stem cells and their bone\u00a0marrow microenvironment. Cell 129: 1081\u20131095","journal-title":"Cell"},{"key":"BFEMBR201439583_CR86","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","volume":"19","author":"DS Krause","year":"2013","unstructured":"Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP, Lezeau S, Attar E, Wu JY, Lin HY et\u00a0al (2013) Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med 19: 1513\u20131517","journal-title":"Nat Med"},{"key":"BFEMBR201439583_CR87","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature12883","volume":"506","author":"A Kode","year":"2014","unstructured":"Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R et\u00a0al (2014) Leukemogenesis induced by an activating \u03b2\u2010catenin mutation in osteoblasts. Nature 506: 240\u2013244","journal-title":"Nature"},{"key":"BFEMBR201439583_CR88","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","volume":"111","author":"J\u2010H Klusmann","year":"2008","unstructured":"Klusmann J\u2010H, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, Pekrun A, Macakova\u2010Reinhardt K, Reinhardt D (2008) Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 111: 2991\u20132998","journal-title":"Blood"},{"key":"BFEMBR201439583_CR89","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2003.08.060","volume":"21","author":"AS Gamis","year":"2003","unstructured":"Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO, Children's Cancer Group Study 2891 (2003) Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. J Clin Oncol 21: 3415\u20133422","journal-title":"J Clin Oncol"},{"key":"BFEMBR201439583_CR90","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1101\/gad.1903410","volume":"24","author":"J\u2010H Klusmann","year":"2010","unstructured":"Klusmann J\u2010H, Godinho FJ, Heitmann K, Maroz A, Koch ML, Reinhardt D, Orkin SH, Li Z (2010) Developmental stage\u2010specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev 24: 1659\u20131672","journal-title":"Genes Dev"},{"key":"BFEMBR201439583_CR91","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1182\/blood-2009-09-242107","volume":"115","author":"AP Ng","year":"2010","unstructured":"Ng AP, Hyland CD, Metcalf D, Carmichael CL, Loughran SJ, Di Rago L, Kile BT, Alexander WS (2010) Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood 115: 3966\u20133969","journal-title":"Blood"},{"key":"BFEMBR201439583_CR92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20091617","volume":"426","author":"JA Birchler","year":"2010","unstructured":"Birchler JA (2010) Reflections on studies of gene expression in aneuploids. Biochem J 426: 119\u2013123","journal-title":"Biochem J"},{"key":"BFEMBR201439583_CR93","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature13200","volume":"508","author":"A Letourneau","year":"2014","unstructured":"Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, Chevalier C, Thurman R, Sandstrom RS, Hibaoui Y et\u00a0al (2014) Domains of genome\u2010wide gene expression dysregulation in Down's syndrome. Nature 508: 345\u2013350","journal-title":"Nature"},{"key":"BFEMBR201439583_CR94","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","volume":"441","author":"JR Arron","year":"2006","unstructured":"Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK et\u00a0al (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441: 595\u2013600","journal-title":"Nature"},{"key":"BFEMBR201439583_CR95","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1101\/gad.233791.113","volume":"28","author":"S Emmrich","year":"2014","unstructured":"Emmrich S, Rasche M, Schoening J, Reimer C, Keihani S, Maroz A, Xie Y, Li Z, Schambach A, Reinhardt D et\u00a0al (2014) miR99a\/100~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGF\u03b2 and Wnt signalling. Genes Dev 28: 858\u2013874","journal-title":"Genes Dev"},{"key":"BFEMBR201439583_CR96","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1101\/gad.1856210","volume":"24","author":"JH Klusmann","year":"2010","unstructured":"Klusmann JH, Li Z, Bohmer K, Maroz A, Koch ML, Emmrich S, Godinho FJ, Orkin SH, Reinhardt D (2010b) miR\u2010125b\u20102 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 24: 478\u2013490","journal-title":"Genes Dev"},{"key":"BFEMBR201439583_CR97","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2012-10-460998","volume":"122","author":"Y Birger","year":"2013","unstructured":"Birger Y, Goldber L, Chlon TM, Goldenson B, Muler I, Schiby G, Jacob\u2010Hirsch J, Rechavi G, Crispino JD, Izraeli S (2013) Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder. Blood 122: 988\u2013998","journal-title":"Blood"},{"key":"BFEMBR201439583_CR98","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ng.2949","volume":"46","author":"AA Lane","year":"2014","unstructured":"Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend EC, van Bodegom D, Day TA, Wu SC, Liu H et\u00a0al (2014) Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nat Genet 46: 618\u2013623","journal-title":"Nat Genet"},{"key":"BFEMBR201439583_CR99","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1158\/0008-5472.CAN-09-0075","volume":"69","author":"S Salek\u2010Ardakani","year":"2009","unstructured":"Salek\u2010Ardakani S, Smooha G, de Boer J, Sebire NJ, Morrow M, Rainis L, Lee S, Williams O, Izraeli S, Brady HJ (2009) ERG is a megakaryocytic oncogene. Cancer Res 69: 4665\u20134673","journal-title":"Cancer Res"},{"key":"BFEMBR201439583_CR100","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.0511150103","volume":"103","author":"JP Bourquin","year":"2006","unstructured":"Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, Baruchel A, Cave H, Dastugue N, Hasle H et\u00a0al (2006) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA 103: 3339\u20133344","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR101","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/leu.2008.371","volume":"23","author":"K Hussein","year":"2009","unstructured":"Hussein K, Bock O, Theophile K, Schultz\u2010Bischof K, Porwit A, Schlue J, Jonigk D, Kreipe H (2009) MPLW515L mutation in acute megakaryoblastic leukaemia. Leukemia 23: 852\u2013855","journal-title":"Leukemia"},{"key":"BFEMBR201439583_CR102","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato\u2010Otsubo A, Sanada M, Park MJ, Terui K, Suzuki H et\u00a0al (2013) The landscape of somatic mutations in Down syndrome\u2010related myeloid disorders. Nat Genet 45: 1293\u20131299","journal-title":"Nat Genet"},{"key":"BFEMBR201439583_CR103","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","volume":"3","author":"Y Pikman","year":"2006","unstructured":"Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I et\u00a0al (2006) MPLW515L is a novel somatic mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3: e270","journal-title":"PLoS Med"},{"key":"BFEMBR201439583_CR104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0921-8734(91)90013-2","volume":"256","author":"G Carmeliet","year":"1991","unstructured":"Carmeliet G, David G, Cassiman JJ (1991) Cellular ageing of Alzheimer's disease and Down syndrome cells in culture. Mutat Res 256: 221\u2013231","journal-title":"Mutat Res"},{"key":"BFEMBR201439583_CR105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.freeradbiomed.2005.03.023","volume":"39","author":"M Kimura","year":"2005","unstructured":"Kimura M, Cao X, Skurnick J, Cody M, Soteropoulos P, Aviv A (2005) Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. Free Radic Biol Med 39: 374\u2013380","journal-title":"Free Radic Biol Med"},{"key":"BFEMBR201439583_CR106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","volume":"397","author":"JJ Jacobs","year":"1999","unstructured":"Jacobs JJ, Lieboom K, Marino S, DePinho RA, van Lohuizen M (1999) The oncogene and Polycomb\u2010group gene bmi regulates cell proliferation and senescence through the ink4 locus. Nature 397: 164\u2013168","journal-title":"Nature"},{"key":"BFEMBR201439583_CR107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","volume":"130","author":"M Collado","year":"2007","unstructured":"Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130: 223\u2013233","journal-title":"Cell"},{"key":"BFEMBR201439583_CR108","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.tcb.2014.06.005","volume":"24","author":"J Gil","year":"2014","unstructured":"Gil J, O'Loghlen A (2014) PRC1 complex diversity: where is it taking us? Trends Cell Biol 24: 632\u2013641","journal-title":"Trends Cell Biol"},{"key":"BFEMBR201439583_CR109","first-page":"547","volume":"5","author":"GK Jacobsen","year":"1992","unstructured":"Jacobsen GK, Henriques UV (1992) A fetal testis with intratubular germ cell neoplasia (ITGCN). Mod Pathol 5: 547\u2013549","journal-title":"Mod Pathol"},{"key":"BFEMBR201439583_CR110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/15513819609168666","volume":"16","author":"D Satge","year":"1996","unstructured":"Satge D, Jacobsen GK, Cessot F, Raffi F, Vekemans M (1996) A fetus with Down syndrome and intratubular germ cell neoplasia. Pediatr Pathol Lab Med 16: 107\u2013112","journal-title":"Pediatr Pathol Lab Med"},{"key":"BFEMBR201439583_CR111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature06446","volume":"451","author":"TE Sussan","year":"2008","unstructured":"Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH (2008) Trisomy represses Apc(Min)\u2010mediated tumours in mouse models of Down's syndrome. Nature 451: 73\u201375","journal-title":"Nature"},{"key":"BFEMBR201439583_CR112","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature08062","volume":"459","author":"KH Baek","year":"2009","unstructured":"Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T et\u00a0al (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126\u20131130","journal-title":"Nature"},{"key":"BFEMBR201439583_CR113","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/0008-5472.CAN-10-4489","volume":"71","author":"A Yang","year":"2011","unstructured":"Yang A, Reeves RH (2011) Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome. Cancer Res 71: 3573\u20133581","journal-title":"Cancer Res"},{"key":"BFEMBR201439583_CR114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N","volume":"217","author":"JT Richtsmeier","year":"2000","unstructured":"Richtsmeier JT, Baxter LL, Reeves RH (2000) Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn 217: 137\u2013145","journal-title":"Dev Dyn"},{"key":"BFEMBR201439583_CR115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajmg.10175","volume":"107","author":"JT Richtsmeier","year":"2002","unstructured":"Richtsmeier JT, Zumwalt A, Carlson EJ, Epstein CJ, Reeves RH (2002) Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am J Med Genet 107: 317\u2013324","journal-title":"Am J Med Genet"},{"key":"BFEMBR201439583_CR116","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000088130","volume":"66","author":"PA Trainor","year":"2005","unstructured":"Trainor PA (2005) Specification and patterning of neural crest cells during craniofacial development. Brain Behav Evol 66: 266\u2013280","journal-title":"Brain Behav Evol"},{"key":"BFEMBR201439583_CR117","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mod.2008.11.002","volume":"126","author":"RJ Roper","year":"2009","unstructured":"Roper RJ, VanHorn JF, Cain CC, Reeves RH (2009) A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev 126: 212\u2013219","journal-title":"Mech Dev"},{"key":"BFEMBR201439583_CR118","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/hmg\/ddr033","volume":"20","author":"S Trazzi","year":"2011","unstructured":"Trazzi S, Mitrugno VM, Valli E, Fuchs C, Rizzi S, Guidi S, Perini G, Bartesaghi R, Ciani E (2011) APP\u2010dependent up\u2010regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. Hum Mol Genet 20: 1560\u20131573","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR119","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1073\/pnas.0510750103","volume":"103","author":"RJ Roper","year":"2006","unstructured":"Roper RJ, Baxter LL, Saran NG, Klinedinst DK, Beachy PA, Reeves RH (2006) Defective cerebellar response to mitogenic Hedgehog signaling in Down's syndrome mice. Proc Natl Acad Sci USA 103: 1452\u20131456","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR120","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/ajmg.a.36006","volume":"161","author":"CN Billingsley","year":"2013","unstructured":"Billingsley CN, Allen JR, Baumann DD, Deitz SL, Blazek JD, Newbauer A, Darrah A, Long BC, Young B, Clement M et\u00a0al (2013) Non\u2010trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome. Am J Med Genet A 161: 1866\u20131874","journal-title":"Am J Med Genet A"},{"key":"BFEMBR201439583_CR121","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1101\/gad.9.21.2646","volume":"9","author":"I Matsuo","year":"1995","unstructured":"Matsuo I, Kuratani S, Kimura C, Takeda N, Aizawa S (1995) Mouse Otx2 functions in the formation and patterning of rostral head. Genes Dev 9: 2646\u20132658","journal-title":"Genes Dev"},{"key":"BFEMBR201439583_CR122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0925-4773(01)00618-9","volume":"111","author":"K Degenhardt","year":"2002","unstructured":"Degenhardt K, Rentschler S, Fishman G, Sassoon DA (2002) Cellular and cis\u2010regulation of En\u20102 expression in the mandibular arch. Mech Dev 111: 125\u2013136","journal-title":"Mech Dev"},{"key":"BFEMBR201439583_CR123","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/379534a0","volume":"379","author":"SH Sumarsono","year":"1996","unstructured":"Sumarsono SH, Wilson TJ, Tymms MJ, Ventner DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A, Kola I (1996) Down's syndrome\u2010like skeletal abnormalities in Ets2 transgenic mice. Nature 379: 534\u2013537","journal-title":"Nature"},{"key":"BFEMBR201439583_CR124","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1460-9568.2008.06092.x","volume":"27","author":"B Hammerle","year":"2008","unstructured":"Hammerle B, Lizalde C, Tejedor FJ (2008) The spatio\u2010temporal and\u00a0subcellular expression of the candidate Down syndrome gene Mnb\/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Eur J Neurosci 27: 1061\u20131074","journal-title":"Eur J Neurosci"},{"key":"BFEMBR201439583_CR125","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","volume":"10","author":"X Altafaj","year":"2001","unstructured":"Altafaj X, Dierssen M, Baamonde C, Marti E, Visa J, Guimera J, Oset M, Gonzalez JR, Florez J, Fillat C et\u00a0al (2001) Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet 10: 1915\u20131923","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR126","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1098992","volume":"306","author":"LE Olson","year":"2004","unstructured":"Olson LE, Richtsmeier J, Leszl J, Reeves RH (2004) A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306: 687\u2013690","journal-title":"Science"},{"key":"BFEMBR201439583_CR127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.20337","volume":"480","author":"PV Belichenko","year":"2004","unstructured":"Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC (2004) Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 480: 281\u2013298","journal-title":"J Comp Neurol"},{"key":"BFEMBR201439583_CR128","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/ajmg.a.33012","volume":"149","author":"CA Hill","year":"2009","unstructured":"Hill CA, Sussan TE, Reeves RH, Richtsmeier JT (2009) Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic \u201cDown syndrome\u201d mice. Am J Med Genet A 149: 2158\u20132165","journal-title":"Am J Med Genet A"},{"key":"BFEMBR201439583_CR129","doi-asserted-by":"crossref","first-page":"20817","DOI":"10.1074\/jbc.M113.451088","volume":"288","author":"S Trazzi","year":"2013","unstructured":"Trazzi S, Fuchs C, Valli E, Perini G, Bartesaghi R, Ciani E (2013) The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. J Biol Chem 288: 20817\u201320829","journal-title":"J Biol Chem"},{"key":"BFEMBR201439583_CR130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","volume":"35","author":"TF Haydar","year":"2012","unstructured":"Haydar TF, Reeves RH (2012) Trisomy 21 and early brain development. Trends Neurosci 35: 81\u201391","journal-title":"Trends Neurosci"},{"key":"BFEMBR201439583_CR131","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hipo.20308","volume":"17","author":"A Contestabile","year":"2007","unstructured":"Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E (2007) cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17: 665\u2013678","journal-title":"Hippocampus"},{"key":"BFEMBR201439583_CR132","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","volume":"18","author":"S Guidi","year":"2008","unstructured":"Guidi S, Bonasoni P, Ceccarelli C, Santini D, Gualtieri F, Ciani E, Bartesaghi R (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol 18: 180\u2013197","journal-title":"Brain Pathol"},{"key":"BFEMBR201439583_CR133","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1750-3639.2010.00459.x","volume":"21","author":"S Guidi","year":"2011","unstructured":"Guidi S, Caina E, Bonasoni P, Santini D, Bartesaghi R (2011) Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome. Brain Pathol 21: 361\u2013373","journal-title":"Brain Pathol"},{"key":"BFEMBR201439583_CR134","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/hmg\/9.2.195","volume":"9","author":"LL Baxter","year":"2000","unstructured":"Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000) Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9: 195\u2013202","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2006.05.022","volume":"1104","author":"HA Lorenzi","year":"2006","unstructured":"Lorenzi HA, Reeves RH (2006) Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res 1104: 153\u2013159","journal-title":"Brain Res"},{"key":"BFEMBR201439583_CR136","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1523\/JNEUROSCI.3406-07.2007","volume":"27","author":"L Chakrabarti","year":"2007","unstructured":"Chakrabarti L, Galdzicki Z, Haydar TF (2007) Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the\u00a0Ts65Dn mouse model of Down syndrome. J Neurosci 27: 11483\u201311495","journal-title":"J Neurosci"},{"key":"BFEMBR201439583_CR137","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1523\/JNEUROSCI.0534-10.2010","volume":"30","author":"P Bianchi","year":"2010","unstructured":"Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, Grossi G, Fernandez M, Giuliani A, Calza L, Bartesaghi R (2010) Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci 30: 8769\u20138779","journal-title":"J Neurosci"},{"key":"BFEMBR201439583_CR138","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1750-3639.2008.00168.x","volume":"19","author":"A Contestabile","year":"2009","unstructured":"Contestabile A, Fila T, Bartesaghi R, Ciani E (2009) Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for Down syndrome. Brain Pathol 19: 224\u2013237","journal-title":"Brain Pathol"},{"key":"BFEMBR201439583_CR139","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2012.11.017","volume":"52","author":"X Altafaj","year":"2013","unstructured":"Altafaj X, Martin ED, Ortiz\u2010Abalia J, Valderrama A, Lao\u2010Peregrin C, Dierssen M, Fillat C (2013) Normalization of Dyrk1a expression by AAV2\/1\u2010shDyrk1A attenuates hippocampal\u2010dependent defects in the\u00a0Ts65Dn mouse model of Down syndrome. Neurobiol Dis 52: 117\u2013127","journal-title":"Neurobiol Dis"},{"key":"BFEMBR201439583_CR140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/hmg\/ddm022","volume":"16","author":"LE Olson","year":"2007","unstructured":"Olson LE, Roper RJ, Sengstaken CL, Peterson EA, Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH (2007) Trisomy for the Down syndrome \u2018critical region\u2019 is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet 16: 774\u2013782","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439583_CR141","first-page":"201ra120","volume":"5","author":"I Das","year":"2013","unstructured":"Das I, Park JM, Shin JH, Jeon SK, Lorenzi H, Linden DJ, Worley PF, Reeves RH (2013) Hedgehog agonist therapy corrects structural and cognitive defects in a Down syndrome mouse model. Sci Transl Med 5: 201ra120","journal-title":"Sci Transl Med"},{"key":"BFEMBR201439583_CR142","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/brain\/awt340","volume":"137","author":"S Guidi","year":"2014","unstructured":"Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, Moldrich R, Kurniawan N, Mardon K, Giulani A et\u00a0al (2014) Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. Brain 137: 380\u2013401","journal-title":"Brain"},{"key":"BFEMBR201439583_CR143","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2014.03.003","volume":"67","author":"S Trazzi","year":"2014","unstructured":"Trazzi S, Fuchs C, De Franceschi M, Mitrugno VM, Bartesaghi R, Ciani E (2014) APP\u2010dependent alteration of GSK3\u03b2 activity impairs neurogenesis in the 65Dn mouse model of Down syndrome. Neurobiol Dis 67: 24\u201336","journal-title":"Neurobiol Dis"},{"key":"BFEMBR201439583_CR144","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0896-6273(00)80682-0","volume":"22","author":"RJ Wechsler\u2010Reya","year":"1999","unstructured":"Wechsler\u2010Reya RJ, Scott MP (1999) Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22: 103\u2013114","journal-title":"Neuron"},{"key":"BFEMBR201439583_CR145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","volume":"11","author":"EM Hur","year":"2010","unstructured":"Hur EM, Zhou FQ (2010) GSK3 signalling in neural development. Nat Rev Neurosci 11: 539\u2013551","journal-title":"Nat Rev Neurosci"},{"key":"BFEMBR201439583_CR146","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.expneurol.2006.02.005","volume":"200","author":"S Clark","year":"2006","unstructured":"Clark S, Schwalbe J, Stasko MR, Yarowsky PJ, Costa AC (2006) Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome. Exp Neurol 200: 256\u2013261","journal-title":"Exp Neurol"},{"key":"BFEMBR201439583_CR147","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","volume":"46","author":"F Guedi","year":"2012","unstructured":"Guedi F, Pereira PL, Najas S, Barallobre MJ, Chabert C, Souchet B, Sebrie C, Verney C, Herault Y, Arbones M et\u00a0al (2012) DYRK1A: a master regulatory protein controlling brain growth. Neurobiol Dis 46: 190\u2013203","journal-title":"Neurobiol Dis"},{"key":"BFEMBR201439583_CR148","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1523\/JNEUROSCI.2852-13.2014","volume":"34","author":"A Thomazeau","year":"2014","unstructured":"Thomazeau A, Lassalle O, Iafrati J, Souchet B, Guedi F, Janel J, Chavis P, Delabar J, Manzoni OJ (2014) Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. J Neurosci 34: 1138\u20131147","journal-title":"J Neurosci"},{"key":"BFEMBR201439583_CR149","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2014.04.016","volume":"69","author":"B Souchet","year":"2014","unstructured":"Souchet B, Guedi F, Sahun I, Duchon A, Daubigny F, Badel A, Yanagawa Y, Barallaobre MJ, Dierssen M, Yu E et\u00a0al (2014) Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage. Neurobiol Dis 69: 65\u201375","journal-title":"Neurobiol Dis"},{"key":"BFEMBR201439583_CR150","doi-asserted-by":"crossref","first-page":"e106572","DOI":"10.1371\/journal.pone.0106572","volume":"9","author":"S Garcia\u2010Cerro","year":"2014","unstructured":"Garcia\u2010Cerro S, Martinez P, Vidal V, Corrales A, Florez J, Vidal R, Rueda N, Arbones M, Martinez\u2010Cue C (2014) Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome. PLoS ONE 9: e106572","journal-title":"PLoS ONE"},{"key":"BFEMBR201439583_CR151","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ajhg.2008.09.010","volume":"83","author":"J Ortiz\u2010Abalia","year":"2008","unstructured":"Ortiz\u2010Abalia J, Sahun I, Altafaj X, Andreu N, Estivill X, Dierssen M, Fillat C (2008) Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome. Am J Hum Genet 83: 479\u2013488","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201439583_CR152","doi-asserted-by":"crossref","first-page":"e1003515","DOI":"10.1371\/journal.pgen.1003515","volume":"9","author":"Y Hibaoui","year":"2013","unstructured":"Hibaoui Y, Grad I, Letourneau A, Sailani MR, Dahoun S, Santoni FA, Gimelli S, Guipponi M, Pelte MF, Bene F et\u00a0al (2013) Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. PLoS Genet 9: e1003515","journal-title":"PLoS Genet"},{"key":"BFEMBR201439583_CR153","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ajhg.2008.08.012","volume":"83","author":"C Canzonetta","year":"2008","unstructured":"Canzonetta C, Mulligan C, Deutsch S, Ruf S, O'Doherty A, Lyle R, Borel C, Lin\u2010Marq N, Delom F, Groet J et\u00a0al (2008) DYRK1A\u2010dosage imbalance perturbs NRSF\/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet 83: 388\u2013400","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201439583_CR154","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2012.10.016","volume":"239","author":"M Hijazi","year":"2013","unstructured":"Hijazi M, Fillat C, Medina JM, Velasco A (2013) Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome. Exp Neurol 239: 229\u2013234","journal-title":"Exp Neurol"},{"key":"BFEMBR201439583_CR155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/dvdy.21416","volume":"237","author":"AD Williams","year":"2008","unstructured":"Williams AD, Mjaatvedt CH, Moore CS (2008) Characterization of the\u00a0cardiac phenotype in neonatal Ts65Dn mice. Dev Dyn 237: 426\u2013435","journal-title":"Dev Dyn"},{"key":"BFEMBR201439583_CR156","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cvr\/cvq193","volume":"88","author":"L Dunlevy","year":"2010","unstructured":"Dunlevy L, Bennett M, Slender A, Lana\u2010Elola E, Tybulewicz VL, Fisher EM, Mohun T (2010) Down's syndrome\u2010like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse. Cardiovasc Res 88: 287\u2013295","journal-title":"Cardiovasc Res"},{"key":"BFEMBR201439583_CR157","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00439-013-1407-z","volume":"133","author":"C Liu","year":"2014","unstructured":"Liu C, Morishima M, Jiang X, Yu T, Meng K, Ray D, Pao A, Ye P, Parmacek MS, Yu YE (2014) Engineered chromosome\u2010based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome\u2010associated heart defects in mice. Hum Genet 133: 743\u2013753","journal-title":"Hum Genet"},{"key":"BFEMBR201439583_CR158","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/labinvest.2012.117","volume":"92","author":"C Fuchs","year":"2012","unstructured":"Fuchs C, Ciani E, Guidi S, Trazzi S, Bartesaghi R (2012) Early\u2010occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression. Lab Invest 92: 1648\u20131660","journal-title":"Lab Invest"},{"key":"BFEMBR201439583_CR159","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2164-8-268","volume":"8","author":"A Conti","year":"2007","unstructured":"Conti A, Fabbrini F, D'Agostino P, Negri R, Greco D, Genesio R, D'Armiento M, Olla C, Paladini D, Zannini M et\u00a0al (2007) Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genom 8: 268","journal-title":"BMC Genom"},{"key":"BFEMBR201439583_CR160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ydbio.2011.02.029","volume":"353","author":"N Bertrand","year":"2011","unstructured":"Bertrand N, Roux M, Ryckebusch L, Niederreither K, Dolle P, Moon A, Capecchi M, Zaffran S (2011) Hox genes define distinct progenitor sub\u2010domains within the second heart field. Dev Biol 353: 266\u2013274","journal-title":"Dev Biol"},{"key":"BFEMBR201439583_CR161","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-1242-1_3","volume":"1196","author":"B Laforest","year":"2014","unstructured":"Laforest B, Bertrand N, Zaffran S (2014) Genetic lineage tracing of anterior Hox expressing cells. Methods Mol Biol 1196: 37\u201348","journal-title":"Methods Mol Biol"},{"key":"BFEMBR201439583_CR162","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1242\/dev.016147","volume":"135","author":"MM Goddeeris","year":"2008","unstructured":"Goddeeris MM, Rho S, Petiet A, Davenport CL, Jihnson GA, Meyers EN, Klingensmith J (2008) Intracardiac septation requires hedgehog\u2010dependent cellular contributions from outside the heart. Development 135: 1887\u20131895","journal-title":"Development"},{"key":"BFEMBR201439583_CR163","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1242\/dev.034157","volume":"136","author":"AD Hoffmann","year":"2009","unstructured":"Hoffmann AD, Peterson MA, Friedland\u2010Little JM, Anderson SA, Moskowitz IP (2009) Sonic hedgehog is required in pulmonary endoderm for atrial septation. Development 136: 1761\u20131770","journal-title":"Development"},{"key":"BFEMBR201439583_CR164","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1242\/dev.128.9.1531","volume":"128","author":"Y Dor","year":"2001","unstructured":"Dor Y, Camenisch TD, Itin A, Fishman GI, McDonald JA, Carmeliet P, Kesheti E (2001) A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 128: 1531\u20131538","journal-title":"Development"},{"key":"BFEMBR201439583_CR165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.gde.2013.05.004","volume":"23","author":"S Yuan","year":"2013","unstructured":"Yuan S, Zaidi S, Brueckman M (2013) Congenital heart disease: emerging themes linking genetics and development. Curr Opin Genet Dev 23: 352\u2013359","journal-title":"Curr Opin Genet Dev"},{"key":"BFEMBR201439583_CR166","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ajhg.2012.08.017","volume":"91","author":"C Ackerman","year":"2012","unstructured":"Ackerman C, Locke AE, Feingold E, Reshey B, Espana K, Thusberg J, Mooney S, Bean LJ, Dooley KJ, Cua CL et\u00a0al (2012) An excess of deleterious variants in VEGF\u2010A pathway genes in Down\u2010syndrome\u2010associated atrioventricular septal defects. Am J Hum Genet 91: 646\u2013659","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201439583_CR167","doi-asserted-by":"crossref","first-page":"239ps","DOI":"10.1126\/scitranslmed.3008921","volume":"6","author":"E Matsa","year":"2014","unstructured":"Matsa E, Burridge PW, Wu JC (2014) Human stem cells for modelling heart disease and for drug discovery. Sci Trans Med 6: 239ps","journal-title":"Sci Trans Med"},{"key":"BFEMBR201439583_CR168","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5966\/sctm.2013-0105","volume":"3","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Habibollah S, Tilgner K, Collin J, Barta T, Al\u2010Aama JY, Tesarov L, Hussain R, Trafford AW, Kirkwood G et\u00a0al (2014) An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional defects in HLHS\u2010derived cardiac myocytes. Stem Cells Trans Med 3: 416\u2013423","journal-title":"Stem Cells Trans Med"},{"key":"BFEMBR201439583_CR169","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.scr.2013.11.008","volume":"12","author":"A Copplola","year":"2014","unstructured":"Copplola A, Romito A, Borel C, Gehrig C, Gagnebin M, Falconnet E, Izzo A, Altucci L, Banfi S, Antonarakis SE et\u00a0al (2014) Cardiomyogenesis is controlled by the miR99a\/let\u20107c cluster and epigenetic modification. Stem Cell Res 12: 323\u2013337","journal-title":"Stem Cell Res"},{"key":"BFEMBR201439583_CR170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2013-03-491936","volume":"122","author":"SI Nikolaev","year":"2013","unstructured":"Nikolaev SI, Santoni F, Vannier A, Falconnet E, Giarin E, Basso G, Hoischen A, Veltman JA, Groet J, Nizetic D, et\u00a0al (2013) Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. Blood 122: 554\u2013561","journal-title":"Blood"},{"key":"BFEMBR201439583_CR171","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tig.2013.04.004","volume":"29","author":"RA Veitia","year":"2013","unstructured":"Veitia RA, Bottani S, Birchler JA (2013) Gene dosage effects: nonlinearities, genetic interactions, and dosage compensation. Trends Genet 29: 385\u2013393","journal-title":"Trends Genet"},{"key":"BFEMBR201439583_CR172","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1073\/pnas.1209227109","volume":"109","author":"JM Sheltzer","year":"2012","unstructured":"Sheltzer JM, Torres EM, Dunham MJ, Amon A (2012) Transcriptional consequences of aneuploidy. Proc Natl Acad Sci USA 109: 12644\u201312649","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR173","doi-asserted-by":"crossref","first-page":"14746","DOI":"10.1073\/pnas.1207726109","volume":"109","author":"JA Birchler","year":"2012","unstructured":"Birchler JA, Veitia RA (2012) Gene balance hypothesis: connecting issues of dosage sensitivity across biological disciplines. Proc Natl Acad Sci USA 109: 14746\u201314753","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR174","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nature12394","volume":"500","author":"J Jiang","year":"2013","unstructured":"Jiang J, Jing Y, Cost GJ, Chiang JC, Kolpa HJ, Cotton AM, Carone DM, Carone BR, Shivak DA, Guschin DY et\u00a0al (2013) Translating dosage compensation to trisomy 21. Nature 500: 296\u2013300","journal-title":"Nature"},{"key":"BFEMBR201439583_CR175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1755-8794-6-24","volume":"6","author":"B Granese","year":"2013","unstructured":"Granese B, Scala I, Spatuzza C, Vlaentino A, Coletta M, Vacca RA, De Luca P, Andria G (2013) Validation of microarray data in human lymphoblasts shows a role of the ubiquitin\u2010proteasome system and NF\u2010kB in the pathogenesis of Down syndrome. BMC Med Genomics 6: 24","journal-title":"BMC Med Genomics"},{"key":"BFEMBR201439583_CR176","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.stem.2012.08.004","volume":"11","author":"LB Li","year":"2012","unstructured":"Li LB, Chang KH, Wang PR, Hirata RK, Papayannopoulou T, Rissell DW (2012) Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell 11: 615\u2013619","journal-title":"Cell Stem Cell"},{"key":"BFEMBR201439583_CR177","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00335-008-9121-1","volume":"19","author":"CY Chou","year":"2008","unstructured":"Chou CY, Liu LY, Chen CY, Tsai CH, Hwa HL, Chang LY, Lin YS, Hsieh FJ (2008) Gene expression variation increase in trisomy 21 tissues. Mamm Genome 19: 398\u2013405","journal-title":"Mamm Genome"},{"key":"BFEMBR201439583_CR178","doi-asserted-by":"crossref","first-page":"9425","DOI":"10.1073\/pnas.0903909106","volume":"106","author":"DK Slonim","year":"2009","unstructured":"Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW (2009) Functional genomic analysis of amniotic fluid cell\u2010free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci USA 106: 9425\u20139429","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR179","doi-asserted-by":"crossref","first-page":"e74184","DOI":"10.1371\/journal.pone.0074184","volume":"8","author":"M Volk","year":"2013","unstructured":"Volk M, Mayer A, Lovrecic L, Luvan P, Peterlin B (2013) Expression signature as a biomarker for prenatal diagnosis of trisomy 21. PLoS ONE 8: e74184","journal-title":"PLoS ONE"},{"key":"BFEMBR201439583_CR180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000112058","volume":"119","author":"O Altug\u2010Teber","year":"2007","unstructured":"Altug\u2010Teber O, Bonin M, Walter M, Mau\u2010Holzmann UA, Dufke A, Stappert H, Tekesin I, Heilbronner H, Nieselt K, Reiss O (2007) Specific transcriptional changes in human fetuses with autosomal trisomies. Cytogenet Genome Res 119: 171\u2013184","journal-title":"Cytogenet Genome Res"},{"key":"BFEMBR201439583_CR181","doi-asserted-by":"crossref","first-page":"e49130","DOI":"10.1371\/journal.pone.0049130","volume":"7","author":"C Li","year":"2012","unstructured":"Li C, Jin L, Bai Y, Chen Q, Fu L, Yang M, Xiao H, Zhao G, Wang S (2012) Genome\u2010wide expression analysis in Down syndrome: onsight into immunodeficiency. PLoS ONE 7: e49130","journal-title":"PLoS ONE"},{"key":"BFEMBR201439583_CR182","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/leu.2011.128","volume":"25","author":"MG Loudin","year":"2011","unstructured":"Loudin MG, Wang J, Leung HC, Gurusiddappa S, Meyer J, Condos G, Morrison D, Tsimelzon A, Devidas M, Heerema NA et\u00a0al (2011) Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia 25: 1555\u20131563","journal-title":"Leukemia"},{"key":"BFEMBR201439583_CR183","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2141.2004.04982.x","volume":"125","author":"S McElwaine","year":"2004","unstructured":"McElwaine S, Mullighan C, Groet J, Spinelli M, Rinaldi A, Denyer G, Mensah A, Cavani S, Baldo C, Dagna\u2010Bricarelli F et\u00a0al (2004) Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker. Br J Haematol 125: 729\u2013742","journal-title":"Br J Haematol"},{"key":"BFEMBR201439583_CR184","doi-asserted-by":"crossref","first-page":"e27486","DOI":"10.1371\/journal.pone.0027486","volume":"6","author":"AC Xavier","year":"2011","unstructured":"Xavier AC, Edawards H, Dombkowski AA, Balci TB, Berman JN, Dellaire G, Xie C, Buck SA, Matherly LH, Ge Y et\u00a0al (2011) A unique role of Gata1s in Down syndrome acute megakaryocytic leukemia biology and therapy. PLoS ONE 6: e27486","journal-title":"PLoS ONE"},{"key":"BFEMBR201439583_CR185","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/leu.2013.373","volume":"28","author":"A Maroz","year":"2014","unstructured":"Maroz A, Stachorski L, Emmrich S, Reinhardt K, Xu J, Shao Z, K\u00e4bler S, Dertmann T, Hitzler J, Roberts I et\u00a0al (2014) GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. Leukemia 28: 1259\u20131270","journal-title":"Leukemia"},{"key":"BFEMBR201439583_CR186","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/gb-2005-6-13-r107","volume":"6","author":"R Mao","year":"2005","unstructured":"Mao R, Wang X, Spitznagel EL, Frelin LP, Ting JC, Ding H, Kim JW, Ruczinski I, Downey TJ, Pevsner J (2005) Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol 6: R107","journal-title":"Genome Biol"},{"key":"BFEMBR201439583_CR187","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/stem.1297","volume":"31","author":"JA Briggs","year":"2013","unstructured":"Briggs JA, Sun J, Shepherd J, Ovchinnikov DA, Chung TL, Nayler SP, Kao LP, Morrow CA, Thakar NY, Soo SY et\u00a0al (2013) Integration\u2010free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology. Stem Cells 31: 467\u2013478","journal-title":"Stem Cells"},{"key":"BFEMBR201439583_CR188","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","volume":"17","author":"P Helguera","year":"2013","unstructured":"Helguera P, Seiglie J, Rodriguez J, Hanna M, Helguera G, Busciglio J (2013) Adaptive downregulation of mitochondrial function in down syndrome. Cell Metab 17: 132\u2013140","journal-title":"Cell Metab"},{"key":"BFEMBR201439583_CR189","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","volume":"90","author":"HE Lockstone","year":"2007","unstructured":"Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S (2007) Gene expression profiling in the adult Down syndrome brain. Genomics 90: 647\u2013660","journal-title":"Genomics"},{"key":"BFEMBR201439583_CR190","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1073\/pnas.1216575110","volume":"110","author":"JP Weick","year":"2013","unstructured":"Weick JP, Held DL, Bonadurer GF, Doers ME, Liu Y, Maguire C, Clark A, Knackert JA, Molinarolo K, Musser M et\u00a0al (2013) Deficits in human\u00a0trisomy 21 iPSCs and neurons. Proc Natl Acad Sci USA 110: 9962\u20139967","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439583_CR191","doi-asserted-by":"crossref","first-page":"e1003515","DOI":"10.1371\/journal.pgen.1003515","volume":"9","author":"S Jin","year":"2013","unstructured":"Jin S, Lee YK, Lim YC, Zheng Z, Lin XM, Ng DP, Holbrook JD, Law HY, Kwek KY, Yeo GS et\u00a0al (2013) Global DNA hypermethylation in down syndrome placenta. PLoS Genet 9: e1003515","journal-title":"PLoS Genet"},{"key":"BFEMBR201439583_CR192","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2164-10-138","volume":"10","author":"J Laffaire","year":"2009","unstructured":"Laffaire J, Rivals I, Dauphinot L, Pasteau F, Wherle R, Larrat B, Vitalis T, Moldrich RX, Rossier J, Sinkus R et\u00a0al (2009) Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genom 10: 138","journal-title":"BMC Genom"},{"key":"BFEMBR201439583_CR193","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jmedgenet-2013-101644","volume":"50","author":"JH Schuurs\u2010Hoeijmakers","year":"2013","unstructured":"Schuurs\u2010Hoeijmakers JH, Vulto\u2010van Silfhout AT, Vissers LE, van de Vondervoort II, van Bon BW, de Ligt J, Gilissen C, Hehir\u2010Kwa JY, Neveling K, del Rosario M et\u00a0al (2013) Identification of pathogenic gene variants in small families with intellectually disabled siblings by exome sequencing. J Med Genet 50: 802\u2013811","journal-title":"J Med Genet"},{"key":"BFEMBR201439583_CR194","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1203\/01.pdr.0000190580.88391.9a","volume":"59","author":"AM Guihard\u2010Costa","year":"2006","unstructured":"Guihard\u2010Costa AM, Khung S, Delbecque K, Menez F, Delezoide AL (2006) Biometry of face and brain in fetuses with trisomy 21. Pediatr Res 59: 33\u201338","journal-title":"Pediatr Res"},{"key":"BFEMBR201439583_CR195","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ajmg.1320470530","volume":"47","author":"JE Allanson","year":"1993","unstructured":"Allanson JE, O'Hara P, Farkas LG, Nair RC (1993) Anthropometric craniofacial pattern profiles in Down syndrome. Am J Med Genet 47: 748\u2013752","journal-title":"Am J Med Genet"},{"key":"BFEMBR201439583_CR196","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrendo.2009.80","volume":"5","author":"Y Hawli","year":"2009","unstructured":"Hawli Y, Nasrallah M, El\u2010Hajj Fuleihan G (2009) Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 5: 327\u2013334","journal-title":"Nat Rev Endocrinol"},{"key":"BFEMBR201439583_CR197","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2788.2012.01536.x","volume":"57","author":"T Patterson","year":"2013","unstructured":"Patterson T, Rapsey CM, Glue P (2013) Systematic review of cognitive development across childhood in Down syndrome: implications for treatment interventions. J Intellect Disab Res 57: 306\u2013318","journal-title":"J Intellect Disab Res"},{"key":"BFEMBR201439583_CR198","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","volume":"51","author":"ML Margallo\u2010Lana","year":"2007","unstructured":"Margallo\u2010Lana ML, Moore PB, Kay DW, Perry RH, Reid BE, Berney TP, Tyrer SP (2007) Fifteen\u2010year follow up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res 51: 463\u2013477","journal-title":"J Intellect Disabil Res"},{"key":"BFEMBR201439583_CR199","doi-asserted-by":"crossref","first-page":"463909","DOI":"10.1155\/2012\/463909","volume":"2012","author":"JP Lockrow","year":"2012","unstructured":"Lockrow JP, Fortress AM, Granholm AC (2012) Age\u2010related neurodegeneration and memory loss in down syndrome. Curr Gerontol Geriatr Res 2012: 463909","journal-title":"Curr Gerontol Geriatr Res"},{"key":"BFEMBR201439583_CR200","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2007-3252","volume":"122","author":"KN Carroll","year":"2008","unstructured":"Carroll KN, Arbogast PG, Dudley JA, Cooper WO (2008) Increase in incidence of medically treated thyroid disease in children with Down syndrome after release of American Academy of Pediatrics Health Supervision guidelines. Pediatrics 122: e493\u2013e498","journal-title":"Pediatrics"},{"key":"BFEMBR201439583_CR201","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ecl.2012.08.008","volume":"41","author":"E Graber","year":"2012","unstructured":"Graber E, Chacko E, Regelmann MO, Costin G, Rapaport R (2012) Down syndrome and thyroid function. Endocrinol Metab Clin North Am 41: 735\u2013745","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFEMBR201439583_CR202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8","volume":"80","author":"SB Freeman","year":"1998","unstructured":"Freeman SB, Taft LF, Dooley KJ, Allran K, Sherman SL, Hassold TJ, Khoury MJ, Saker DM (1998) Population\u2010based study of congenital heart disease in Down syndrome. Am J Hum Genet 80: 213\u2013217","journal-title":"Am J Hum Genet"},{"key":"BFEMBR201439583_CR203","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00431-010-1200-0","volume":"169","author":"ME Weijerman","year":"2010","unstructured":"Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJ, Gemke RJ (2010) Prevalence of congenital heart disease and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 169: 1195\u20131199","journal-title":"Eur J Pediatr"},{"key":"BFEMBR201439583_CR204","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jpeds.2013.11.032","volume":"164","author":"NJ Roizen","year":"2014","unstructured":"Roizen NJ, Magyar CI, Kuschner ES, Sulkes SB, Druschel C, van Wijngaarden E, Rodgers L, Diehl A, Lowry R, Hyman SL (2014) A community cross\u2010sectional survey of medical problems in 440 children with Down syndrome in New York State. J Pediatr 164: 871\u2013875","journal-title":"J Pediatr"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201439583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.201439583","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.201439583\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.201439583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201439583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:50:08Z","timestamp":1779108608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.201439583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":204,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"alternative-id":["BFEMBR201439583"],"URL":"https:\/\/doi.org\/10.15252\/embr.201439583","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]},"assertion":[{"value":"14 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}